Logo image of MBLY

MOBILEYE GLOBAL INC-A (MBLY) Stock Fundamental Analysis

USA - Nasdaq - NASDAQ:MBLY - US60741F1049 - Common Stock

10.17 USD
+0.01 (+0.1%)
Last: 12/24/2025, 5:00:01 PM
10.14 USD
-0.03 (-0.29%)
After Hours: 12/24/2025, 5:00:01 PM
Fundamental Rating

5

Overall MBLY gets a fundamental rating of 5 out of 10. We evaluated MBLY against 43 industry peers in the Automobile Components industry. While MBLY has a great health rating, there are worries on its profitability. MBLY has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

In the past year MBLY was profitable.
In the past year MBLY had a positive cash flow from operations.
In the past 5 years MBLY always reported negative net income.
In the past 5 years MBLY always reported a positive cash flow from operatings.
MBLY Yearly Net Income VS EBIT VS OCF VS FCFMBLY Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 0 -1B -2B -3B

1.2 Ratios

Looking at the Return On Assets, with a value of -2.69%, MBLY is doing worse than 60.47% of the companies in the same industry.
MBLY's Return On Equity of -2.82% is in line compared to the rest of the industry. MBLY outperforms 51.16% of its industry peers.
Industry RankSector Rank
ROA -2.69%
ROE -2.82%
ROIC N/A
ROA(3y)-8.42%
ROA(5y)-5.38%
ROE(3y)-8.77%
ROE(5y)-5.6%
ROIC(3y)N/A
ROIC(5y)N/A
MBLY Yearly ROA, ROE, ROICMBLY Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 -5 -10 -15 -20 -25

1.3 Margins

MBLY has a better Gross Margin (48.66%) than 95.35% of its industry peers.
In the last couple of years the Gross Margin of MBLY has remained more or less at the same level.
MBLY does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 48.66%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.76%
GM growth 5Y-1.42%
MBLY Yearly Profit, Operating, Gross MarginsMBLY Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 0 50 -50 -100 -150

8

2. Health

2.1 Basic Checks

MBLY does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, MBLY has more shares outstanding
MBLY has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
MBLY Yearly Shares OutstandingMBLY Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 200M 400M 600M 800M
MBLY Yearly Total Debt VS Total AssetsMBLY Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 5B 10B 15B

2.2 Solvency

MBLY has an Altman-Z score of 8.98. This indicates that MBLY is financially healthy and has little risk of bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 8.98, MBLY belongs to the top of the industry, outperforming 88.37% of the companies in the same industry.
MBLY has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 8.98
ROIC/WACCN/A
WACC8.6%
MBLY Yearly LT Debt VS Equity VS FCFMBLY Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 5B 10B 15B

2.3 Liquidity

A Current Ratio of 6.46 indicates that MBLY has no problem at all paying its short term obligations.
MBLY has a Current ratio of 6.46. This is amongst the best in the industry. MBLY outperforms 93.02% of its industry peers.
A Quick Ratio of 5.61 indicates that MBLY has no problem at all paying its short term obligations.
MBLY has a Quick ratio of 5.61. This is amongst the best in the industry. MBLY outperforms 93.02% of its industry peers.
Industry RankSector Rank
Current Ratio 6.46
Quick Ratio 5.61
MBLY Yearly Current Assets VS Current LiabilitesMBLY Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 500M 1B 1.5B 2B

6

3. Growth

3.1 Past

MBLY shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 7.50%.
Looking at the last year, MBLY shows a small growth in Revenue. The Revenue has grown by 7.61% in the last year.
The Revenue has been growing by 13.48% on average over the past years. This is quite good.
EPS 1Y (TTM)7.5%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-10%
Revenue 1Y (TTM)7.61%
Revenue growth 3Y6.07%
Revenue growth 5Y13.48%
Sales Q2Q%3.7%

3.2 Future

Based on estimates for the next years, MBLY will show a very strong growth in Earnings Per Share. The EPS will grow by 53.12% on average per year.
The Revenue is expected to grow by 26.67% on average over the next years. This is a very strong growth
EPS Next Y46.12%
EPS Next 2Y29.7%
EPS Next 3Y35.21%
EPS Next 5Y53.12%
Revenue Next Year14.1%
Revenue Next 2Y10.75%
Revenue Next 3Y14.89%
Revenue Next 5Y26.67%

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
MBLY Yearly Revenue VS EstimatesMBLY Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2B 4B 6B
MBLY Yearly EPS VS EstimatesMBLY Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 2026 2027 2028 2029 2030 0.5 1 1.5 2 2.5

4

4. Valuation

4.1 Price/Earnings Ratio

MBLY is valuated rather expensively with a Price/Earnings ratio of 23.65.
MBLY's Price/Earnings is on the same level as the industry average.
The average S&P500 Price/Earnings ratio is at 26.59. MBLY is around the same levels.
A Price/Forward Earnings ratio of 24.18 indicates a rather expensive valuation of MBLY.
Based on the Price/Forward Earnings ratio, MBLY is valued a bit more expensive than the industry average as 62.79% of the companies are valued more cheaply.
When comparing the Price/Forward Earnings ratio of MBLY to the average of the S&P500 Index (24.03), we can say MBLY is valued inline with the index average.
Industry RankSector Rank
PE 23.65
Fwd PE 24.18
MBLY Price Earnings VS Forward Price EarningsMBLY Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of MBLY indicates a slightly more expensive valuation: MBLY is more expensive than 60.47% of the companies listed in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of MBLY indicates a somewhat cheap valuation: MBLY is cheaper than 67.44% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 13.18
EV/EBITDA 45.76
MBLY Per share dataMBLY EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10

4.3 Compensation for Growth

MBLY's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
MBLY's earnings are expected to grow with 35.21% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.51
PEG (5Y)N/A
EPS Next 2Y29.7%
EPS Next 3Y35.21%

0

5. Dividend

5.1 Amount

MBLY does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

MOBILEYE GLOBAL INC-A

NASDAQ:MBLY (12/24/2025, 5:00:01 PM)

After market: 10.14 -0.03 (-0.29%)

10.17

+0.01 (+0.1%)

Chartmill FA Rating
GICS IndustryGroupAutomobiles & Components
GICS IndustryAutomobile Components
Earnings (Last)10-23 2025-10-23/bmo
Earnings (Next)01-28 2026-01-28/amc
Inst Owners75.24%
Inst Owner Change88.88%
Ins Owners2.12%
Ins Owner Change23.85%
Market Cap8.28B
Revenue(TTM)1.94B
Net Income(TTM)-336.00M
Analysts74.44
Price Target19.59 (92.63%)
Short Float %15.19%
Short Ratio5.04
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)12.99%
Min EPS beat(2)2.78%
Max EPS beat(2)23.2%
EPS beat(4)4
Avg EPS beat(4)11.44%
Min EPS beat(4)2.78%
Max EPS beat(4)23.2%
EPS beat(8)7
Avg EPS beat(8)7.16%
EPS beat(12)11
Avg EPS beat(12)15.37%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)2.92%
Min Revenue beat(2)2.68%
Max Revenue beat(2)3.17%
Revenue beat(4)3
Avg Revenue beat(4)1.27%
Min Revenue beat(4)-1.33%
Max Revenue beat(4)3.17%
Revenue beat(8)6
Avg Revenue beat(8)0.85%
Revenue beat(12)7
Avg Revenue beat(12)0.51%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-0.18%
PT rev (3m)-1.93%
EPS NQ rev (1m)-1.9%
EPS NQ rev (3m)14.97%
EPS NY rev (1m)-0.32%
EPS NY rev (3m)5.16%
Revenue NQ rev (1m)0.19%
Revenue NQ rev (3m)3.42%
Revenue NY rev (1m)0.42%
Revenue NY rev (3m)2.08%
Valuation
Industry RankSector Rank
PE 23.65
Fwd PE 24.18
P/S 4.27
P/FCF 13.18
P/OCF 11.94
P/B 0.69
P/tB 3.37
EV/EBITDA 45.76
EPS(TTM)0.43
EY4.23%
EPS(NY)0.42
Fwd EY4.14%
FCF(TTM)0.77
FCFY7.59%
OCF(TTM)0.85
OCFY8.37%
SpS2.38
BVpS14.67
TBVpS3.02
PEG (NY)0.51
PEG (5Y)N/A
Graham Number11.91
Profitability
Industry RankSector Rank
ROA -2.69%
ROE -2.82%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 48.66%
FCFM 32.4%
ROA(3y)-8.42%
ROA(5y)-5.38%
ROE(3y)-8.77%
ROE(5y)-5.6%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.76%
GM growth 5Y-1.42%
F-Score7
Asset Turnover0.16
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 12.65%
Cap/Sales 3.35%
Interest Coverage N/A
Cash Conversion 541.41%
Profit Quality N/A
Current Ratio 6.46
Quick Ratio 5.61
Altman-Z 8.98
F-Score7
WACC8.6%
ROIC/WACCN/A
Cap/Depr(3y)18.23%
Cap/Depr(5y)20.31%
Cap/Sales(3y)5.18%
Cap/Sales(5y)7.06%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)7.5%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-10%
EPS Next Y46.12%
EPS Next 2Y29.7%
EPS Next 3Y35.21%
EPS Next 5Y53.12%
Revenue 1Y (TTM)7.61%
Revenue growth 3Y6.07%
Revenue growth 5Y13.48%
Sales Q2Q%3.7%
Revenue Next Year14.1%
Revenue Next 2Y10.75%
Revenue Next 3Y14.89%
Revenue Next 5Y26.67%
EBIT growth 1Y-4.04%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year135.13%
EBIT Next 3Y55.54%
EBIT Next 5Y50.04%
FCF growth 1Y90.88%
FCF growth 3Y-11.23%
FCF growth 5Y4.5%
OCF growth 1Y58.95%
OCF growth 3Y-12.59%
OCF growth 5Y5.92%

MOBILEYE GLOBAL INC-A / MBLY FAQ

What is the fundamental rating for MBLY stock?

ChartMill assigns a fundamental rating of 5 / 10 to MBLY.


What is the valuation status of MOBILEYE GLOBAL INC-A (MBLY) stock?

ChartMill assigns a valuation rating of 4 / 10 to MOBILEYE GLOBAL INC-A (MBLY). This can be considered as Fairly Valued.


Can you provide the profitability details for MOBILEYE GLOBAL INC-A?

MOBILEYE GLOBAL INC-A (MBLY) has a profitability rating of 3 / 10.


Can you provide the financial health for MBLY stock?

The financial health rating of MOBILEYE GLOBAL INC-A (MBLY) is 8 / 10.


What is the earnings growth outlook for MOBILEYE GLOBAL INC-A?

The Earnings per Share (EPS) of MOBILEYE GLOBAL INC-A (MBLY) is expected to grow by 46.12% in the next year.